The American College of Physicians criticized that the 2017 blood pressure (BP) guideline may fall short in weighing the potential benefits against potential harms, costs, and anticipated variation in individual patient preferences, especially for average- and lower-risk adults 60 and older. Other experts echoed some of the same concerns, arguing against a one-size-fits-all BP goal. It may be reasonable to consider more aggressive treatment goals in the highest-risk patients. For everyone else, it may be more reasonable to continue defining hypertension as a BP of 140/90 mm Hg or higher and to take an individualized approach, especially for those with poor vascular compliance (i.e., pulse pressures above 80 to 90 mm Hg), who typically have dizziness and poor mentation as their systolic BP approaches 140 mm Hg; for many people over 70 with isolated systolic hypertension. Source: http://annals.org/; http://www.nejm.org/
A rigorous cohort study utilizing Taiwan’s National Health Insurance Database provides robust evidence that SGLT2…
A new study investigating the link between cerebral microbleeds (CMBs) and dementia has found that…
A comprehensive prospective study tracking over 159,000 adults for up to three decades has provided…
A comprehensive new Cochrane review of 22 studies involving nearly 2,000 participants over six months…
A large-scale study involving 103,649 UK Biobank participants has revealed that adhering to healthy dietary…
To address uncertainties in statin safety profiles, which are often based on observational data susceptible…
This website uses cookies.